scholarly article | Q13442814 |
P50 | author | Pablo Engel | Q38362432 |
Susana Kalko | Q41049953 | ||
P2093 | author name string | Xavier Romero | |
Victoria Tovar | |||
Pilar Pizcueta | |||
Miguel Angel de la Fuente | |||
María Calvo | |||
Charlotte Ockeloen | |||
Nuria Zapater | |||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunology | Q101929 |
P304 | page(s) | 7033-7042 | |
P577 | publication date | 2005-06-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | CD229 (Ly9) lymphocyte cell surface receptor interacts homophilically through its N-terminal domain and relocalizes to the immunological synapse | |
P478 | volume | 174 |
Q28115070 | A polymorphism in a phosphotyrosine signalling motif of CD229 (Ly9, SLAMF3) alters SH2 domain binding and T-cell activation |
Q50105046 | A prominent role of the human cytomegalovirus UL8 glycoprotein restraining pro-inflammatory cytokine production by myeloid cells at late times during infection |
Q91474383 | Bone marrow dendritic cells support the survival of chronic lymphocytic leukemia cells in a CD84 dependent manner |
Q37228462 | CD84 is a survival receptor for CLL cells |
Q51620105 | CD84 mediates CLL-microenvironment interactions. |
Q57047056 | CD84 regulates PD-1/PD-L1 expression and function in chronic lymphocytic leukemia |
Q50674400 | Characterization of mouse CD229 (Ly9), a leukocyte cell surface molecule of the CD150 (SLAM) family. |
Q36493007 | Cutting edge: Ly9 (CD229), a SLAM family receptor, negatively regulates the development of thymic innate memory-like CD8+ T and invariant NKT cells. |
Q27329902 | Cytomegalovirus m154 hinders CD48 cell-surface expression and promotes viral escape from host natural killer cell control |
Q83224332 | Cytomegalovirus protein m154 perturbs the adaptor protein-1 compartment mediating broad-spectrum immune evasion |
Q60912961 | Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions |
Q42406915 | Differential expression of CD150 (SLAM) family receptors by human hematopoietic stem and progenitor cells |
Q37200094 | Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus |
Q36302329 | Follicular B helper T cells in antibody responses and autoimmunity. |
Q28584820 | Homotypic interactions mediated by Slamf1 and Slamf6 receptors control NKT cell lineage development |
Q39525113 | Human cytomegalovirus UL7, a homologue of the SLAM-family receptor CD229, impairs cytokine production |
Q38166716 | Human plasmacytoid dendritic cells: from molecules to intercellular communication network |
Q49818504 | Ibrutinib and idelalisib block immunophenotypic changes associated with the adhesion and activation of CLL cells in the tumor microenvironment |
Q24316447 | Large-scale screening for novel low-affinity extracellular protein interactions |
Q59798154 | Ly9 (CD229) Antibody Targeting Depletes Marginal Zone and Germinal Center B Cells in Lymphoid Tissues and Reduces Salivary Gland Inflammation in a Mouse Model of Sjögren's Syndrome |
Q37057979 | Ly9 (CD229) Cell-Surface Receptor is Crucial for the Development of Spontaneous Autoantibody Production to Nuclear Antigens. |
Q34796596 | Mice lacking the SLAM family member CD84 display unaltered platelet function in hemostasis and thrombosis |
Q28504904 | Migration of myeloid cells during inflammation is differentially regulated by the cell surface receptors Slamf1 and Slamf8 |
Q28591247 | Mouse CD84 is a pan-leukocyte cell-surface molecule that modulates LPS-induced cytokine secretion by macrophages |
Q61658983 | Prevalence and evolutionary origins of autoimmune susceptibility alleles in natural mouse populations |
Q36883146 | Roles of CD48 in regulating immunity and tolerance |
Q34401723 | Sequence, structure, function, immunity: structural genomics of costimulation. |
Q36281793 | Signaling Lymphocytic Activation Molecule Family Receptor Homologs in New World Monkey Cytomegaloviruses |
Q52584346 | Signaling lymphocytic activation molecules Slam and cancers: friends or foes? |
Q92272826 | Signalling lymphocyte activation molecule family member 9 is found on select subsets of antigen-presenting cells and promotes resistance to Salmonella infection |
Q36447603 | Targeting of Ly9 (CD229) Disrupts Marginal Zone and B1 B Cell Homeostasis and Antibody Responses |
Q64105034 | The Checkpoint Regulator SLAMF3 Preferentially Prevents Expansion of Auto-Reactive B Cells Generated by Graft-vs.-Host Disease |
Q35692343 | The Role of Plasmacytoid Dendritic Cells in Innate and Adaptive Immune Responses against Alpha Herpes Virus Infections |
Q34781617 | The SLAM and SAP gene families control innate and adaptive immune responses. |
Q39268482 | The SLAM family member CD84 is regulated by ADAM10 and calpain in platelets |
Q88576833 | The SLAM family receptors: Potential therapeutic targets for inflammatory and autoimmune diseases |
Q35187797 | The expression of the hepatocyte SLAMF3 (CD229) receptor enhances the hepatitis C virus infection |
Q37811046 | The role of SAP and SLAM family molecules in the humoral immune response |
Q36704486 | The role of SLAM family receptors in immune cell signaling |
Q37811280 | The role of SLAM/CD2 polymorphisms in systemic autoimmunity |
Q37810323 | X-linked lymphoproliferative syndrome: a genetic condition typified by the triad of infection, immunodeficiency and lymphoma. |